Drug discovery and development company SCYNEXIS, Inc. (Nasdaq:SCYX) announced that Yves J. Ribeill, Ph.D., SCYNEXIS’ President and Chief Executive Officer, will present at the 9(th) Annual JMP Securities Healthcare Conference at the Westin Grand Central Hotel in New York City on Tuesday, June 24, 2014, at 3:00 p.m. ET. SCYNEXIS Inc (NASDAQ:SCYX) weekly performance is -14.18%. On last trading day company shares ended up $9.83. Analysts mean target price for the company is $16.00. SCYNEXIS Inc (NASDAQ:SCYX) distance from 50-day simple moving average is -12.18%.
On May 13,2014 Sophiris Bio Inc (NASDAQ:SPHS) a biopharmaceutical company developing a clinical-stage, targeted treatment for the symptoms of benign prostatic hyperplasia (BPH) or enlarged prostate, announced financial results and recent key operational highlights for the three months ended March 31, 2014. Sophiris Bio Inc (NASDAQ:SPHS) shares fell -0.45% in last trading session and ended the day on $2.19. SPHS its return on assets is -50.90%. Sophiris Bio Inc (NASDAQ:SPHS) quarterly performance is -40.00%.
Ruthigen Inc. (Nasdaq: RTGN) on Thursday announced regulatory approval to advance testing of a new antibiotic for surgery and wound care. The decision by the Food and Drug Administration cleared the RUT58-60 compound for use in Ruthigen’s first trial, expected to encompass 30 patients and July of 2014. Ruthigen Inc (NASDAQ:RTGN) shares moved down -13.01% in last trading session and was closed at $5.75, while trading in range of $5.75-$6.63. Ruthigen Inc (NASDAQ:RTGN) year to date performance is -20.69%.
Lightbeam Health Solutions announced that it has contracted with USMD Holdings Inc (NASDAQ:USMD) to deploy the Lightbeam population health platform to support USMD’s CMS ACO population as well as several other at-risk reimbursement programs. USMD Holdings Inc (NASDAQ:USMD) ended the last trading day at $11.41. Company weekly volatility is calculated as 7.02% and price to cash ratio as 11.35. USMD Holdings Inc (NASDAQ:USMD) showed a negative weekly performance of -8.43%.